Skip to main content
. 2019 Sep 17;2019:3862024. doi: 10.1155/2019/3862024

Figure 1.

Figure 1

Serum Golgi protein 73 (GP73) levels were gradually increased along with liver disease progression in patients with chronic HCV infection. (a) Comparison of serum GP73 levels in the healthy control (HC), Cohort A, and Cohort B. (b) Comparison of serum GP73 levels in the healthy control (HC), precirrhotic chronic hepatitis C (pre-Cir CHC), compensated liver cirrhosis (CLC), and decompensated liver cirrhosis (DLC) patients in Cohort A. (c) Comparison of serum GP73 levels in different scores of Child-Pugh. ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001.